featured
Dapagliflozin and Prevention of Kidney Disease in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes-Post Hoc Analyses From the DECLARE-TIMI 58 Trial
Diabetes Care 2022 Aug 23;[EPub Ahead of Print], O Mosenzon, I Raz, SD Wiviott, M Schechter, EL Goodrich, I Yanuv, A Rozenberg, SA Murphy, TA Zelniker, AM Langkilde, IAM Gause-Nilsson, M Fredriksson, PA Johansson, JPH Wilding, DK McGuire, DL Bhatt, LA Leiter, A Cahn, JP Dwyer, HJL Heerspink, MS SabatineFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.